Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Ionis Pharmaceuticals
IONS
$9.4B
| $90.4M | 0.02% |
1,533,785
+42,720
| +3% | +$2.38M |
|
602
Chegg
CHGG
$102M
| $90.3M | 0.02% |
1,341,878
-276,970
| -17% | -$14.8M |
|
603
UGI
UGI
$7.33B
| $90M | 0.02% |
2,833,120
+22
| +0% | +$667 |
|
604
Spotify
SPOT
$100B
| $89.6M | 0.02% |
346,894
+45,127
| +15% | +$7.74M |
|
605
Ally Financial
ALLY
$13.3B
| $89.3M | 0.02% |
4,506,855
-47,110
| -1% | -$802K |
|
606
Elanco Animal Health
ELAN
$11.1B
| $89.2M | 0.02% |
4,162,175
+50,684
| +1% | +$1.12M |
|
607
OGE Energy
OGE
$9.71B
| $89M | 0.02% |
2,934,849
-106,619
| -4% | -$3.3M |
|
608
Chemed
CHE
$7.22B
| $89M | 0.02% |
197,213
-9,082
| -4% | -$4.05M |
|
609
Scotiabank
BNS
$108B
| $88.7M | 0.02% |
2,123,742
+191,739
| +10% | +$7.66M |
|
610
Trex
TREX
$5.01B
| $88.7M | 0.02% |
1,363,964
-356,058
| -21% | -$19M |
|
611
News Corp Class A
NWSA
$15.4B
| $88.7M | 0.02% |
7,489,988
+191,880
| +3% | +$2.05M |
|
|
IMMU
612
DELISTED
Immunomedics Inc
IMMU
| $88.7M | 0.02% |
2,502,182
-271,053
| -10% | -$7.92M |
|
613
TAL Education Group
TAL
$6.87B
| $88.6M | 0.02% |
1,302,481
+260,014
| +25% | +$14.9M |
|
614
Healthcare Realty
HR
$6.84B
| $88.4M | 0.02% |
3,334,627
+937,437
| +39% | +$24M |
|
615
AGNC Investment
AGNC
$12.9B
| $88.1M | 0.02% |
6,831,900
+635
| +0% | +$7.96K |
|
|
PBCT
616
DELISTED
People's United Financial Inc
PBCT
| $88M | 0.02% |
7,622,400
-189,678
| -2% | -$2.21M |
|
617
Exelixis
EXEL
$13.4B
| $87.9M | 0.02% |
3,703,931
+84,837
| +2% | +$1.97M |
|
618
APA Corp
APA
$13.2B
| $87.8M | 0.02% |
6,513,196
+621,612
| +11% | +$7.09M |
|
619
Invesco
IVZ
$13.9B
| $87.8M | 0.02% |
8,139,378
+313,421
| +4% | +$2.81M |
|
620
SolarEdge
SEDG
$1.95B
| $87.5M | 0.02% |
630,642
+197,368
| +46% | +$24.1M |
|
621
Toro Company
TTC
$9.49B
| $86.7M | 0.02% |
1,306,709
+22,944
| +2% | +$1.51M |
|
|
MRO
622
DELISTED
Marathon Oil Corporation
MRO
| $86.6M | 0.02% |
14,170,757
+1,048,876
| +8% | +$5.8M |
|
|
STOR
623
DELISTED
STORE Capital Corporation
STOR
| $86.3M | 0.02% |
3,622,600
+770,641
| +27% | +$15.4M |
|
624
Douglas Emmett
DEI
$1.96B
| $86.2M | 0.02% |
2,812,022
-353,719
| -11% | -$10.6M |
|
|
SEE
625
DELISTED
Sealed Air
SEE
| $84.9M | 0.02% |
2,588,558
+61,844
| +2% | +$1.86M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.